menu
    • menu
    [{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Carbohydrate-Based Breakfast","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"Inulin-Type Fructan","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Undisclosed"},{"orgOrder":0,"company":"Beneo","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GERMANY","productType":"Undisclosed","year":"2018","type":"Inapplicable","leadProduct":"Inulin-Type Fructan","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Undisclosed"},{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Isomaltulose","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"GERMANY","productType":"Dietary Supplement","year":"2019","type":"Inapplicable","leadProduct":"Isomaltulose","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Undisclosed"},{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"ISRAEL","productType":"Dietary Supplement","year":"2014","type":"Inapplicable","leadProduct":"Isomaltulose","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase III","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"10","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"German Sport University, Cologne","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Low Glycaemic Index","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ German Sport University, Cologne","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ German Sport University, Cologne"},{"orgOrder":0,"company":"Beneo","sponsor":"Universitair Ziekenhuis Brussel","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"New Prebiotic Follow-On Formula","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Universitair Ziekenhuis Brussel","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Universitair Ziekenhuis Brussel"},{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2018","type":"Inapplicable","leadProduct":"Oligofructose-Enriched Inulin","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"GERMANY","productType":"Plant Extract\/Herbal","year":"2015","type":"Inapplicable","leadProduct":"Orafti Inulin","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Undisclosed"},{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"SPAIN","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"Oraftir Inulin-Type Fructans","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Prebiotic","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili"},{"orgOrder":0,"company":"Beneo","sponsor":"University of Reading","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Prebiotic","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ University of Reading","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ University of Reading"},{"orgOrder":0,"company":"Beneo","sponsor":"Daacro","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"GERMANY","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Prebiotic Fiber","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Daacro","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Daacro"},{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"CHINA","productType":"Probiotic","year":"2019","type":"Inapplicable","leadProduct":"Prebiotic Fructan","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Vitalose","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ BioTeSys GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals by Beneo

    Menu

    Beneo

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Prebiotic Fiber

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Sponsor : Daacro

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Chicory Root Prebiotic Effects On Mood and Stress In Healthy Adults

                            Details : Prebiotic Fiber is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress Disorders, Traumatic.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            July 10, 2025

                            Lead Product(s) : Prebiotic Fiber

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Sponsor : Daacro

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Low Glycaemic Index

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : German Sport University, Cologne

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Investigating the Effects of Diet and Physical Activity on Esport Performance

                            Details : Low Glycaemic Index is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            May 30, 2023

                            Lead Product(s) : Low Glycaemic Index

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : German Sport University, Cologne

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : New Prebiotic Follow-On Formula

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Universitair Ziekenhuis Brussel

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prebiotic Effects in Healthy Toddlers

                            Details : New Prebiotic Follow-On Formula is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            March 24, 2023

                            Lead Product(s) : New Prebiotic Follow-On Formula

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Universitair Ziekenhuis Brussel

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Isomaltulose

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Recipient : Swansea University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Metabolic Effects of Ultra-endurance Exercise and Training Under Low or High Glycaemic Index-carbohydrate ...

                            Details : Isomaltulose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            August 29, 2022

                            Lead Product(s) : Isomaltulose

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Recipient : Swansea University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Prebiotic

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : University of Reading

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort

                            Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            January 28, 2022

                            Lead Product(s) : Prebiotic

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : University of Reading

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Prebiotic

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prebiotic EffecT InfanTs

                            Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            March 10, 2021

                            Lead Product(s) : Prebiotic

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vitalose

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

                            Details : Vitalose is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            October 22, 2020

                            Lead Product(s) : Vitalose

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Isomaltulose

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Palatinoseâ„¢ Versus Sucrose on Flow Mediated Dilation in Healthy Subjects With Mild Hypertens...

                            Details : Isomaltulose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            June 14, 2019

                            Lead Product(s) : Isomaltulose

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Prebiotic Fructan

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prebiotic Fructans Effect on 1-3 Years Constipated Children's Bowel Habits

                            Details : Prebiotic Fructan is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            May 08, 2019

                            Lead Product(s) : Prebiotic Fructan

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Beneo

                            Germany arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Carbohydrate-Based Breakfast

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : German Institute of Human Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect

                            Details : Carbohydrate-Based Breakfast is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            January 16, 2019

                            Lead Product(s) : Carbohydrate-Based Breakfast

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : German Institute of Human Nutrition

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth